BioLineRx Ltd. , a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for the year ended December 31, 2014. Kinneret Savitsky, Ph.D., CEO of BioLineRx, remarked, "2014 marks a year of significant progress for BioLineRx on multiple fronts, both from a product development perspective, as well as from a business perspective.
http://ift.tt/1N0AaDz
http://ift.tt/1N0AaDz
No comments:
Post a Comment